Fatigue in fluctuating Parkinson's disease patients: possible impact of safinamide.

Authors:
Pauletti C; Locuratolo N; Mannarelli D; Maffucci A; Petritis A and 2 more

Journal:
J Neural Transm (Vienna)

Publication Year: 2023

DOI:
10.1007/s00702-023-02654-1

PMCID:
PMC10293124

PMID:
37210459

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Neural Transm (Vienna)

Abbreviation: J Neural Transm (Vienna)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Physiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Edema related to treatment with psychotropic drugs.
Engel J; Haack B; Zolk O and 9 more (2024) - Transparency Score: 3/6
Functional AGXT2 SNP rs180749 variant and depressive symptoms: Baseline data from the Aidai Cohort …
Kumon H; Miyake Y; Yoshino Y and 8 more (2024) - Transparency Score: 3/6
Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: fo…
Mueller JK; Müller WE. (2024) - Transparency Score: 3/6
Parkinson's disease motor progression in relation to the timing of REM sleep behavior disorder pres…
Bovenzi R; Pierantozzi M; Conti M and 7 more (2024) - Transparency Score: 3/6
Psychometric properties of the Caregiver's inventory neuropsychological diagnosis dementia (CINDD) …
Cuoco S; Blundo C; Ricci M and 9 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Funding: Open access funding provided by Università degli Studi di Roma La Sapienza within the CRUI-CARE Agreement. This study was supported by an unconditioned grant from Zambon to FF. CP has received a speaker honorarium and support for attending scientific meetings from Zambon. There are no other financial disclosures or conflict of interests related to this study."

Evidence found in paper:

"Funding Open access funding provided by Università degli Studi di Roma La Sapienza within the CRUI-CARE Agreement. This study was supported by an unconditioned grant from Zambon to FF. CP has received a speaker honorarium and support for attending scientific meetings from Zambon. There are no other financial disclosures or conflict of interests related to this study."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025